CIPLA GETS EIR FROM US
22 Apr 2019
The popular pharmaceutical company Cipla on Thursday, 4thApril has announced that they have got the Establishment Inspection Report (EIR) from the US health regulator after having the inspection of its Goa facility. From January 21-28, 2019, The US Food and Drug Administration (USFDA) had inspected the Goa manufacturing facility. Then the company received the EIR showing the closure of the inspection. The share market value of the firm closed at Rs. 522.10 per scrip on BSE. And the value was 0.37 percent up from the previous close.
. Designed by